Inverse correlation of parathyroid hormone levels and endothelial function in patients with type 2 diabetes

Introduction:

Increased parathyroid hormone concentrations have been related to cardiovascular mortality. We hypothesized that intact parathyroid hormone (iPTH) levels also negatively correlate with flow-mediated dilatation (FMD).

Methods:

We examined brachial artery FMD, nitroglycerin-mediated dilatation (NMD) and pulse wave velocity (PWV) in participants of the German Diabetes Study (type 1 diabetes, T1DM: n = 19, age 32.6 ± 11.6 years, BMI 26.3 ± 5.3 kg/m², disease duration 1.0 ± 1.6 years; type 2 diabetes, T2DM: n = 32, 53.2 ± 12.3 years, 32.2 ± 5.3 kg/m², 2.1 ± 2.4 years; healthy controls, CON: n = 6, 43.7 ± 14.7 years, 28.2 ± 4.4 kg/m²) using B-mode ultrasonography. iPTH was measured with a chemiluminescence immunometric assay.

Results:

iPTH concentrations were comparable between groups (T1DM: 35.5 ± 16.8, T2DM: 41.3 ± 25.5, CON: 38.4 ± 8.3 pg/ml). Hypertension was present in 0%, 37.5% and 16.7% and dyslipidemia was present in 10.5%, 56.3% and 16.7% (T1DM, T2DM, CON). Only in T2DM, upon adjustment for age, sex and BMI, iPTH correlated negatively with FMD (r =-0.43, p < 0.05). The NMD response was lower in T2DM compared to CON (12.2 ± 4.6% vs. 18.5 ± 4.4%, p < 0.005) and similar to T1DM (13.1 ± 9.1%, n.s.). PWV (15 s after hyperemia) was lower in both T1DM and T2DM (141.4 ± 55.5 cm/s and 128.2 ± 55.0 cm/s vs. CON: 198.9 ± 25.4 cm/s, both p < 0.05). Both NMD response and PWV did not correlate with iPTH.

Conclusion:

Despite short disease duration, endothelial dysfunction is already present in patients with diabetes. Furthermore, iPTH could be an early biomarker for endothelial insulin resistance of T2DM.

 

MissingLinkText

No conflict of interest has been declared by the author(s).